Dr. Frost’s Insider Buy Boosts Cocrystal Pharma Amid Capital Injection, Signaling Strong Growth Potential
Insider Dr. Frost’s $0.94 purchase of 75k Cocrystal shares signals confidence after the firm’s capital raise—watch how this move could spark clinical milestones and partnership breakthroughs in antiviral therapy.
4 minutes to read

